Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: April 13, 2021
Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
Journal: Andrologia
Published: December 07, 2013
Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial.
Journal: Archives of pathology & laboratory medicine
Published: November 29, 2013
Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.
Journal: Neoplasia (New York, N.Y.)
Published: December 19, 2012
Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.
Journal: Neoplasia (New York, N.Y.)
Published: September 27, 2012
Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men.
Journal: Human molecular genetics
Published: September 01, 2012
Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
Journal: Prostate cancer and prostatic diseases
Published: August 30, 2012
A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.
Journal: Genetic epidemiology
Published: August 15, 2012
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
Journal: European urology
Published: February 17, 2012
Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: February 09, 2012
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: January 27, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026